United Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UTHR and other ETFs, options, and stocks.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,168

Employees1,168

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,168

Employees1,168

UTHR Key Statistics

Market cap

11.10B

Market cap11.10B

Price-Earnings ratio

11.96

Price-Earnings ratio11.96

Dividend yield

—

Dividend yield—

Average volume

485.15K

Average volume485.15K

High today

$238.19

High today$238.19

Low today

$234.33

Low today$234.33

Open price

$236.83

Open price$236.83

Volume

364.98K

Volume364.98K

52 Week high

$261.54

52 Week high$261.54

52 Week low

$204.44

52 Week low$204.44

UTHR News

Yahoo Finance 2d

Will United Therapeutics Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Un...

Yahoo Finance 2d

United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Yahoo Finance

A) Genetically modified source pig, 16 to 20 weeks old. B) The thymus is then explanted from the source genetically modified pig, and the thymic tissue is impla...

Analyst ratings

78%

of 18 ratings

Buy

77.8%

Hold

16.7%

Sell

5.6%